<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Montalescot, Gilles</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Education Program Fails to Improve Adherence to Apixaban</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-11-09 11:22:16</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">9-9</style></pages><abstract><style  face="normal" font="default" size="100%">In the AEGEAN study, the addition of an education program to apixaban therapy in patients with atrial fibrillation did not improve patient adherence or persistence to therapy at 24 weeks. The rates of adherence and persistence were high.</style></abstract><number><style face="normal" font="default" size="100%">28 suppl 2</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>